Table 3.
Analysis | Group B vs group A (97.5% Cl) | Group D vs group C (97.5% Cl) | Groups B + D vs groups A + C (95% Cl) | Group C vs group A (97.5% Cl) | Group D vs group B (97.5% Cl) | Groups C + D vs groups A + B (95% Cl) |
---|---|---|---|---|---|---|
Uni/bivariate | ||||||
OR | 1.14 (0.71-1.83) | 1.94 (1.20-3.14) | 1.48 (1.10-1.99) | 0.98 (0.61-1.57) | 1.66 (1.02-2.69) | 1.27 (0.94-1.70) |
P | .53 | .003 | .009 | .92 | .024 | .12 |
Multivariate | ||||||
OR | 1.11 (0.67-1.83) | 1.76 (1.05-2.94) | 1.43 (1.05-1.94) | 0.98 (0.59-1.60) | 1.44 (0.86-2.42) | 1.15 (0.84-1.56) |
P | .65 | .01 | .025 | .90 | .12 | .38 |
Multivariate indicates adjustment for cytogenetics (unknown/not done, favorable, intermediate, unfavorable, other), WBC (<5, 5-24.9, 25-99.9, ≥ 100 × 109/L), age (61-65, 66-75, > 75 years), and disease (de novo AML, sAML).